Pharmacy Times – Expert: MDMA-Assisted Therapy Has Potential Benefits For Women With Hypoactive Sexual Desire Disorder

Aislinn Antrim of Pharmacy Times interviewed MINDCURE CEO Kelsey Ramsden about the company’s Desire Project. They first discussed the nature of the project and its intended goals, followed by current treatments for HSDD in women, the role of MDMA-assisted psychotherapy, the difference between women’s and men’s experiences, and finally how these differences translate into different market options.

Access the interview here.